Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial

10.1159/000503713

Saved in:
Bibliographic Details
Main Authors: Bakris, George L, Agarwal, Rajiv, Anker, Stefan D, Pitt, Bertram, Ruilope, Luis M, Nowack, Christina, Kolkhof, Peter, Ferreira, Anna C, Schloemer, Patrick, Filippatos, Gerasimos, FIGARO-DKD investigators
Other Authors: MEDICINE
Format: Article
Language:English
Published: KARGER 2023
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/246026
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-246026
record_format dspace
spelling sg-nus-scholar.10635-2460262023-11-17T04:05:23Z Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial Bakris, George L Agarwal, Rajiv Anker, Stefan D Pitt, Bertram Ruilope, Luis M Nowack, Christina Kolkhof, Peter Ferreira, Anna C Schloemer, Patrick Filippatos, Gerasimos FIGARO-DKD investigators MEDICINE Science & Technology Life Sciences & Biomedicine Urology & Nephrology Outcomes Clinical Kidney Mineralocorticoid Diabetes Aldosterone MINERALOCORTICOID RECEPTOR ALDOSTERONE BLOCKADE HEART-FAILURE DOUBLE-BLIND BAY 94-8862 ANTAGONIST SPIRONOLACTONE ALBUMINURIA NEPHROPATHY MORTALITY 10.1159/000503713 AMERICAN JOURNAL OF NEPHROLOGY 50 5 333-344 2023-11-17T03:33:34Z 2023-11-17T03:33:34Z 2019-11 2023-11-17T03:22:04Z Article Bakris, George L, Agarwal, Rajiv, Anker, Stefan D, Pitt, Bertram, Ruilope, Luis M, Nowack, Christina, Kolkhof, Peter, Ferreira, Anna C, Schloemer, Patrick, Filippatos, Gerasimos, FIGARO-DKD investigators (2019-11). Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial. AMERICAN JOURNAL OF NEPHROLOGY 50 (5) : 333-344. ScholarBank@NUS Repository. https://doi.org/10.1159/000503713 0250-8095 1421-9670 https://scholarbank.nus.edu.sg/handle/10635/246026 en KARGER Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Urology & Nephrology
Outcomes
Clinical
Kidney
Mineralocorticoid
Diabetes
Aldosterone
MINERALOCORTICOID RECEPTOR
ALDOSTERONE BLOCKADE
HEART-FAILURE
DOUBLE-BLIND
BAY 94-8862
ANTAGONIST
SPIRONOLACTONE
ALBUMINURIA
NEPHROPATHY
MORTALITY
spellingShingle Science & Technology
Life Sciences & Biomedicine
Urology & Nephrology
Outcomes
Clinical
Kidney
Mineralocorticoid
Diabetes
Aldosterone
MINERALOCORTICOID RECEPTOR
ALDOSTERONE BLOCKADE
HEART-FAILURE
DOUBLE-BLIND
BAY 94-8862
ANTAGONIST
SPIRONOLACTONE
ALBUMINURIA
NEPHROPATHY
MORTALITY
Bakris, George L
Agarwal, Rajiv
Anker, Stefan D
Pitt, Bertram
Ruilope, Luis M
Nowack, Christina
Kolkhof, Peter
Ferreira, Anna C
Schloemer, Patrick
Filippatos, Gerasimos
FIGARO-DKD investigators
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
description 10.1159/000503713
author2 MEDICINE
author_facet MEDICINE
Bakris, George L
Agarwal, Rajiv
Anker, Stefan D
Pitt, Bertram
Ruilope, Luis M
Nowack, Christina
Kolkhof, Peter
Ferreira, Anna C
Schloemer, Patrick
Filippatos, Gerasimos
FIGARO-DKD investigators
format Article
author Bakris, George L
Agarwal, Rajiv
Anker, Stefan D
Pitt, Bertram
Ruilope, Luis M
Nowack, Christina
Kolkhof, Peter
Ferreira, Anna C
Schloemer, Patrick
Filippatos, Gerasimos
FIGARO-DKD investigators
author_sort Bakris, George L
title Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
title_short Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
title_full Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
title_fullStr Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
title_full_unstemmed Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
title_sort design and baseline characteristics of the finerenone in reducing kidney failure and disease progression in diabetic kidney disease trial
publisher KARGER
publishDate 2023
url https://scholarbank.nus.edu.sg/handle/10635/246026
_version_ 1783955466143924224